AnGes, Inc.   Report issue

For profit Phase 1 Phase 2 Phase 3
Founded: Tokyo Japan (1999)

Organization Overview

First Clinical Trial
2003
NCT00060892
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2021

Timeline

NOW
  • Now

Alternative names

AnGes | AnGes, Inc. | AnGes USA, Inc.